Decision Ptb Ratio vs Capex To Depreciation Analysis
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics financial indicator trend analysis is much more than just examining Decision Diagnostics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Decision Diagnostics is a good investment. Please check the relationship between Decision Diagnostics Ptb Ratio and its Capex To Depreciation accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
Ptb Ratio vs Capex To Depreciation
Ptb Ratio vs Capex To Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Decision Diagnostics Ptb Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Decision Diagnostics' Ptb Ratio and Capex To Depreciation is -0.06. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Decision Diagnostics, assuming nothing else is changed. The correlation between historical values of Decision Diagnostics' Ptb Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Decision Diagnostics are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Ptb Ratio i.e., Decision Diagnostics' Ptb Ratio and Capex To Depreciation go up and down completely randomly.
Correlation Coefficient | -0.06 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Most indicators from Decision Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Decision Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.At this time, Decision Diagnostics' Tax Provision is very stable compared to the past year. As of the 26th of November 2024, Sales General And Administrative To Revenue is likely to grow to 1.36, while Selling General Administrative is likely to drop about 2.6 M.
| 2019 | 2020 | 2023 | 2024 (projected) | Gross Profit | 850.4K | 498.5K | 448.6K | 774.8K | Total Revenue | 2.4M | 2.0M | 1.8M | 1.7M |
Decision Diagnostics fundamental ratios Correlations
Click cells to compare fundamentals
Decision Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Decision Diagnostics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 5.1M | 4.2M | 5.3M | 5.7M | 6.5M | 5.2M | |
| Total Current Liabilities | 3.2M | 2.8M | 5.0M | 4.9M | 5.7M | 3.5M | |
| Total Stockholder Equity | 1.6M | 1.1M | 87.6K | 483.6K | 435.2K | 413.5K | |
| Net Tangible Assets | 11.1K | (626.8K) | (3.1M) | (2.7M) | (2.5M) | (2.3M) | |
| Retained Earnings | (44.4M) | (46.6M) | (49.7M) | (79.4M) | (71.5M) | (67.9M) | |
| Accounts Payable | 805.6K | 1.0M | 1.3M | 1.7M | 2.0M | 2.1M | |
| Cash | 1.1M | 358.8K | 114.3K | 522.3K | 600.7K | 637.2K | |
| Net Receivables | 437.9K | 949.8K | 1.0M | 943.8K | 849.4K | 1.2M | |
| Total Liab | 3.5M | 3.1M | 5.2M | 5.2M | 5.9M | 3.9M | |
| Total Current Assets | 2.7M | 1.7M | 1.3M | 1.6M | 1.5M | 2.5M | |
| Common Stock | 110.0K | 134.3K | 159.2K | 354.5K | 407.7K | 428.1K | |
| Intangible Assets | 1.6M | 1.7M | 2.5M | 3.2M | 3.7M | 3.9M | |
| Inventory | 316.7K | 250.7K | 166.6K | 160.7K | 184.8K | 219.8K |
Pair Trading with Decision Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.